Strategic Advocates’s Abbott ABT Stock Holding History

Strategic Advocates’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22	Closed	-$2.81K	–	271
2025 Q4	$2.81K	Hold	22	–	–	﹤0.01%	470
2025 Q3	$2.98K	Buy	+22	New	+$2.89K	﹤0.01%	449

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Strategic Advocates's ABT Position: Q1 2026 in Review

Strategic Advocates sold out of Abbott (ABT) in Q1 2026, closing a stake of 22 shares — an estimated $2.81K sold.

Strategic Advocates first reported a position in ABT in Q3 2025 and held it in 2 quarters. The position peaked at $2.98K in Q3 2025. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Strategic Advocates reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 22 Abbott shares in Q1 2026, an estimated $2.81K.
Strategic Advocates first reported a position in Abbott in Q3 2025 and held it in 2 quarters.
Strategic Advocates's Abbott position peaked at $2.98K in Q3 2025.
3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.